|About This Issue|
|Table of Contents|
Timely management of patients presenting to the ED while in their first trimester of pregnancy can improve outcomes for both the patient and the fetus. Common obstetric problems encountered include vaginal bleeding and miscarriage, ectopic pregnancy and pregnancy of undetermined location, and nausea and vomiting of pregnancy, including hyperemesis gravidarum. Optimal diagnostic approaches and management strategies are covered, including which antiemetics are safe to give in pregnancy. Common nonobstetric problems include asymptomatic bacteriuria, urinary tract infections including pyelonephritis, and acute appendicitis. This article also reviews the various imaging modalities available for pregnant patients and reviews the risks of ionizing radiation as well as various contrast media.
Your first patient of the shift is a 23-year-old woman whom the nurse has rushed into the resuscitation bay due to hypotension and altered mental status. The patient's blood pressure is 70/40 mm Hg, with a heart rate of 70 beats/min, and she states that she has had abdominal pain and vaginal bleeding since this morning. You wonder what would be the fastest way to get this patient diagnosed and treated…
The patient in the room next door is a 19-year-old woman who presents due to light vaginal spotting for the past few hours. She says she came in because she has been trying to get pregnant for months, and finally had a positive pregnancy test yesterday. This is her first visit to a doctor since learning of her pregnancy. She is tearful, and asks, “Does this mean I am going to lose my baby?” You are not quite sure how to answer her question, and you ask yourself what tests need to be done today in the ED...
Later that shift, you evaluate a 26-year-old woman who has a confirmed intrauterine pregnancy at 11 weeks’ gestation and presents for fever, dysuria, and right flank pain. An ultrasound was performed in triage that showed bilateral mild hydronephrosis. You are not sure what to make of that finding, which antibiotics would be safe for treatment, and whether she can be managed as an outpatient…
Patients in their first trimester of pregnancy frequently present to the emergency department (ED) with both obstetric and nonobstetric complaints that range from benign to life-threatening for both mother and fetus. Managing these patients is an important skill, but a recent survey demonstrated that only 56% of emergency medicine residents felt they had adequate exposure to obstetric emergencies. On a multiple-choice test covering knowledge of obstetric emergencies, a mean of 58% of items were answered correctly.1 This identifies an important area for further education and training, as timely diagnosis and appropriate management can improve outcomes.
Common obstetric problems in the first trimester of pregnancy include vaginal bleeding and the spectrum of miscarriage (experienced by 7%-27% of pregnant patients)2, nausea and vomiting (85%)3, hyperemesis gravidarum (3%), and ectopic pregnancy (2%)4. Common nonobstetric problems include appendicitis and urinary tract infections (UTIs). The most recent report on pregnancy-related mortality, published in 2017 and encompassing 2011-2013 data for pregnancies in the United States, showed a stable rate of 17 deaths per 100,000 pregnancies, but with significant racial-ethnic disparities.5
This issue of Emergency Medicine Practice reviews important issues that affect patients in their first trimester, management pearls and pitfalls, and a review of the literature surrounding current recommendations.
Medical Subject Headings (MeSH) via PubMed were searched for pregnancy trimester, first (14,929 articles), hyperemesis gravidarum (1379 articles), ectopic pregnancy (13,953 articles), and abortion, spontaneous (34,256 articles). These articles were further limited to English language only, human subjects, and then divided into reviews and clinical trials.
Guidelines from the American College of Obstetricians and Gynecologists (ACOG) were reviewed, including evidence-based Practice Bulletins on critical care in pregnancy (2016)6, medical management of first-trimester abortion (2014)7, tubal ectopic pregnancy (2018)8, nausea and vomiting of pregnancy (2018)9, and prevention of RhD alloimmunization (2017)10. ACOG Committee Opinions on the risk of birth defects with antibiotics for UTI (2017)11 and guidelines for imaging in pregnancy (2017)12 were also reviewed. The American College of Radiology Practice Parameter for imaging of pregnant women (2013)13, a consensus-based guideline based on the review of the available evidence, was reviewed, along with the 2005 guidelines from the Infectious Diseases Society of America (IDSA) on asymptomatic bacteriuria.14
The Cochrane Database of Systematic Reviews has reviews on interventions for nausea and vomiting in pregnancy (2015)15, hyperemesis gravidarum (2016)16, antibiotic regimens for asymptomatic bacteriuria (2010)17, UTIs (2011)18, expectant versus surgical management of miscarriage (2012)19, and medical treatments for incomplete miscarriage (2017)20. Most of these reviews include multiple randomized controlled trials, and the data are generally good for these topics. The American College of Emergency Physicians (ACEP) released a 2017 update on their Clinical Policy, “Critical Issues in the Initial Evaluation and Management of Patients Presenting to the ED in Early Pregnancy,” although no new significant updates were added since their previous 2012 recommendations.21,22
The relevant literature that guides ED management of first trimester emergencies is, overall, very good, and many of the recommendations in this issue of Emergency Medicine Practice can be made based on robust data. Some data, such as the utility of a pelvic examination when an ultrasound is performed, are underpowered to detect potential small, but true, differences in outcomes and are areas for further study.
3. “The patient was 11 weeks’ pregnant and had pyelonephritis; she had a fever and was vomiting, but looked okay, so I sent her home with antibiotics.”
Until further data support initial outpatient management of pyelonephritis, it is best to admit all pregnant patients with pyelonephritis for an initial course of IV antibiotics.
5. “My patient was 10 weeks’ pregnant and had nausea, so I sent her home with 60 tablets of ondansetron.”
Although the risk of birth defects with maternal ondansetron exposure is low, there are safer alternatives for treatment of nausea and vomiting in pregnancy. Pyridoxine or pyridoxine with doxylamine should be considered first-line therapy.
9. “My patient was hypotensive and had a positive pregnancy test. I could not see an IUP, but she had free intraperitoneal fluid. I figured I would rule out other diagnoses with a CT scan, but she coded in the scanner!”
An unstable pregnant patient without an identified IUP with abdominal pain and/or vaginal bleeding has an ectopic pregnancy until proven otherwise. Unstable patients should proceed immediately to surgical management with an obstetrician.
Evidence-based medicine requires a critical appraisal of the literature based upon study methodology and number of subjects. Not all references are equally robust. The findings of a large, prospective, randomized, and blinded trial should carry more weight than a case report.
To help the reader judge the strength of each reference, pertinent information about the study, such as the type of study and the number of patients in the study is included in bold type following the references, where available. In addition, the most informative references cited in this paper, as determined by the author, are highlighted.
Points and Pearls Excerpt
Most Important References
Ryan Pedigo, MD
Jennifer Beck-Esmay, MD; Taku Taira, MD, FACEP
January 1, 2019
January 31, 2022
Physician CME Information
Date of Original Release: January 1, 2019. Date of most recent review: December 15, 2018. Termination date: January 1, 2022.
Accreditation: EB Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. This activity has been planned and implemented in accordance with the accreditation requirements and policies of the ACCME.
Credit Designation: EB Medicine designates this enduring material for a maximum of 4 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
ACEP Accreditation: Emergency Medicine Practice is approved by the American College of Emergency Physicians for 48 hours of ACEP Category I credit per annual subscription.
AAFP Accreditation: This Enduring Material activity, Emergency Medicine Practice, has been reviewed and is acceptable for credit by the American Academy of Family Physicians. Term of approval begins 07/01/2018. Term of approval is for one year from this date. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Approved for 4 AAFP Prescribed credits.
AOA Accreditation: Emergency Medicine Practice is eligible for up to 48 American Osteopathic Association Category 2-A or 2-B credit hours per year.
Specialty CME: Included as part of the 4 credits, this CME activity is eligible for 2 Pharmacology CME credits, subject to your state and institutional approval.
Needs Assessment: The need for this educational activity was determined by a survey of medical staff, including the editorial board of this publication; review of morbidity and mortality data from the CDC, AHA, NCHS, and ACEP; and evaluation of prior activities for emergency physicians.
Target Audience: This enduring material is designed for emergency medicine physicians, physician assistants, nurse practitioners, and residents.
Goals: Upon completion of this activity, you should be able to: (1) demonstrate medical decision-making based on the strongest clinical evidence; (2) cost-effectively diagnose and treat the most critical presentations; and (3) describe the most common medicolegal pitfalls for each topic covered.
Discussion of Investigational Information: As part of the journal, faculty may be presenting investigational information about pharmaceutical products that is outside Food and Drug Administration–approved labeling. Information presented as part of this activity is intended solely as continuing medical education and is not intended to promote off-label use of any pharmaceutical product.
Faculty Disclosures: It is the policy of EB Medicine to ensure objectivity, balance, independence, transparency, and scientific rigor in all CME-sponsored educational activities. All faculty participating in the planning or implementation of a sponsored activity are expected to disclose to the audience any relevant financial relationships and to assist in resolving any conflict of interest that may arise from the relationship. In compliance with all ACCME Essentials, Standards, and Guidelines, all faculty for this CME activity were asked to complete a full disclosure statement. The information received is as follows: Dr. Pedigo, Dr. Beck-Esmay, Dr. Taira, Dr. Mishler, Dr. Toscano, and their related parties report no significant financial interest or other relationship with the manufacturer(s) of any commercial product(s) discussed in this educational presentation. Dr. Jagoda made the following disclosures: Consultant, Daiichi Sankyo Inc; Consultant, Pfizer Inc; Consultant, Banyan Biomarkers Inc.
Commercial Support: This issue of Emergency Medicine Practice did not receive any commercial support.
Earning Credit: Two Convenient Methods: (1) Go online to www.ebmedicine.net/CME and click on the title of the article. (2) Mail or fax the CME Answer And Evaluation Form (included with your June and December issues) to EB Medicine.
Hardware/Software Requirements: You will need a Macintosh or PC to access the online archived articles and CME testing.
Additional Policies: For additional policies, including our statement of conflict of interest, source of funding, statement of informed consent, and statement of human and animal rights, visit www.ebmedicine.net/policies.